Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISA 2022 | What is currently known about AL amyloidosis with cardiac involvement?

Stefano Ricagno • 6 Sep 2022
ISA 2022
Amyloidosis Rare Diseases

Stefano Ricagno, PhD, University of Milan, Milan, Italy, shares some insights into AL amyloidosis with cardiac involvement, emphasizing the need to further research and better understand the molecular underpinnings of cardiotoxicity in this disease. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

More from Stefano Ricagno

1:56
ISA session highlights: basic research on light chains & cardiotoxicity in amyloidosis
Stefano Ricagno • 6 Sep 2022
2:51
The role of protein dynamics and proteolysis in light chain amyloid aggregation
Stefano Ricagno • 6 Sep 2022
1:15
An insight into organ dysfunction and damage in AL amyloidosis
Stefano Ricagno • 6 Sep 2022

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
0:58
Hematological manifestations associated with primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals